145 related articles for article (PubMed ID: 10064405)
1. Cellular leiomyoma mimicking endometrial stromal neoplasm in association with GnRH agonist goserelin.
McCluggage WG; Bharucha H
Histopathology; 1999 Feb; 34(2):184-6. PubMed ID: 10064405
[No Abstract] [Full Text] [Related]
2. Successful hormone treatment of orbital leiomyoma.
Wrede J; Helmke B; Hartmann M; Voelcker HE; Dithmar S
Ophthalmology; 2005 Jul; 112(7):1316-8. PubMed ID: 15921744
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant therapy during the administration of GnRH agonists].
Nikolov A; Kolarov G
Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
[No Abstract] [Full Text] [Related]
5. [GnRH analogues and myomas: which strategy?].
Cohen J
Gynecol Obstet Fertil; 2006 May; 34(5):462. PubMed ID: 16630742
[No Abstract] [Full Text] [Related]
6. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Cramer SF
Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
[No Abstract] [Full Text] [Related]
7. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
Nikolov A; Karag'ozov I
Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of apoptosis by gonadotrophin-releasing hormone agonist in cultures of endometrial cells from women with symptomatic myomas.
Kang JL; Wang DY; Wang XX; Yu J
Hum Reprod; 2010 Sep; 25(9):2270-5. PubMed ID: 20634188
[TBL] [Abstract][Full Text] [Related]
9. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
Scheer ML; Slebos DJ; Bogchelman DH; Timens W
Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin.
Crow J; Gardner RL; McSweeney G; Shaw RW
Int J Gynecol Pathol; 1995 Jul; 14(3):235-42. PubMed ID: 8600075
[TBL] [Abstract][Full Text] [Related]
13. GnRH agonist therapy before myomectomy or hysterectomy.
Gutmann JN; Corson SL
J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
[No Abstract] [Full Text] [Related]
14. Uterine myoma after cessation of gonadotropin-releasing hormone agonist: ultrasound and histopathologic findings.
Wang PH; Yang AH; Yuan CC; Lee WL; Chao HT
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):625-9. PubMed ID: 9872018
[TBL] [Abstract][Full Text] [Related]
15. Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin.
Borsari R; Bozzini N; Junqueira CR; Soares JM; Hilário SG; Baracat EC
Fertil Steril; 2010 Aug; 94(3):1072-7. PubMed ID: 19481745
[TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure.
Bozzini N; Rodrigues CJ; Petti DA; Bevilacqua RG; Gonçalves SP; Pinotti JA
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):330-4. PubMed ID: 12716317
[TBL] [Abstract][Full Text] [Related]
17. [Clinical uses of goserelin in gynecologic diseases and its safety].
Tan SJ; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):58-60. PubMed ID: 10682460
[No Abstract] [Full Text] [Related]
18. Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography.
Lee WL; Liu RS; Yuan CC; Chao HT; Wang PH
Fertil Steril; 2001 Mar; 75(3):638-9. PubMed ID: 11239559
[No Abstract] [Full Text] [Related]
19. Evaluation of goserelin effectiveness based on assessment of inflammatory cytokines and symptoms in uterine leiomyoma.
Mohammed NH; Al-Taie A; Albasry Z
Int J Clin Pharm; 2020 Jun; 42(3):931-937. PubMed ID: 32350747
[TBL] [Abstract][Full Text] [Related]
20. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
